| Name | Title | Contact Details |
|---|---|---|
jose sintas |
Sr. Director R&D | Profile |
Anuradha Raghavan |
Sr. Director- R&D Portfolio Management | Profile |
David Kanios |
Director R&D | Profile |
Mixilexi Cata |
Director, Head of Human Resources | Profile |
Dolores Calicchio |
Vice President of Human Resources | Profile |
Merck Frosst Canada is a Kirkland, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
200 Pharmacy & Home Medical Supplies is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Afexa Life Sciences Inc. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and better.